Press Releases

In a treatment centre in Guinea, DZIF researchers from the Heinrich Pette Institute (HPI) and the Bernhard Nocht Institute (BNITM) have, for the first time, identified the human immune response in

The clinical phase I trial of a potential vaccine against the dreaded Ebola virus has been successfully completed at four partner sites in Africa and Europe. The safety of the tested vaccine “rVSV

An international research group has identified a cellular factor of the human cell that is indispensable to the replication of Human Immunodeficiency Virus (HIV-1). Scientists of the Paul-Ehrlich

World Tuberculosis Day on 24 March is a reminder to the public that 1.5 people still die of tuberculosis (TB) every year. The rise of multidrug-resistant strains is particularly problematic, currently

Many viral diseases tend to become chronic - including infections with the HI virus. Scientists from the DZIF site Bonn-Köln and from the TU München have now identified an immune factor which is

Researchers at the Heinrich Pette Institute, Hamburg, and at the Dresden Technical University (TUD) succeeded in developing a designer enzyme that is capable of specifically removing the provirus from

Scientists led by the Leibniz Research Center Borstel, the Institute of Microbiology and Laboratory Diagnostics in Gauting, the Institute of Medical Microbiology of the University of Zurich and the

In a current clinical trial, a team of scientists including researchers from the DZIF has shown that treating severe malaria in children can be simplified. The results have been published in PLOS

Researchers from the German Center for Infection Research (DZIF) and the University of Giessen have shown that the gene for resistance to colistin, which was recently discovered in China, also exists

For the first time, scientists from the Bernard Nocht Institute for Tropical Medicine (BNITM) including DZIF researchers have, in collaboration with Swiss colleagues, confirmed a long-lasting